Rheumotologitsts’ view on the use of hydroxychloroquine to treat COVID-19
The current pandemic coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) calls urgently for effective therapies. Anti-malarial medicine chloroquine (CQ) and particularly its chemical analogue hydroxychloroquine (HCQ) have been recommended as...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis Group
2020-01-01
|
| Reeks: | Emerging Microbes and Infections |
| Onderwerpen: | |
| Online toegang: | https://www.tandfonline.com/doi/10.1080/22221751.2020.1760145 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|